热门出版物 - 学术资源搜索

h5 指数:78
h5 中位数:108

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#4 Rheumatology

标题/作者	引用次数	年份
The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies F Rees, M Doherty, MJ Grainge, P Lanyon, W Zhang Rheumatology 56 (11), 1945-1961	484	2017
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults C Gordon, MB Amissah-Arthur, M Gayed, S Brown, IN Bruce, D D’Cruz, ... Rheumatology 57 (1), e1-e45	258	2018
The British Society for Rheumatology Guideline for the Management of Gout M Hui, A Carr, S Cameron, G Davenport, M Doherty, H Forrester, ... Rheumatology 56 (7), e1-e20	241	2017
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease C Dejaco, C Duftner, F Buttgereit, EL Matteson, B Dasgupta Rheumatology 56 (4), 506-515	213	2017
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis GE Fragoulis, IB McInnes, S Siebert Rheumatology 58 (Supplement_1), i43-i54	197	2019
The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus MJ Lewis, AS Jawad Rheumatology 56 (suppl_1), i67-i77	171	2017
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis K Bechman, S Subesinghe, S Norton, F Atzeni, M Galli, AP Cope, ... Rheumatology 58 (10), 1755-1766	169	2019
What drives osteoarthritis?—synovial versus subchondral bone pathology T Hügle, J Geurts Rheumatology 56 (9), 1461-1471	160	2017
Update on colchicine, 2017 A Slobodnick, B Shah, S Krasnokutsky, MH Pillinger Rheumatology 57 (suppl_1), i4-i11	160	2018
Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment SJ Carter, RS Tattersall, AV Ramanan Rheumatology 58 (1), 5-17	153	2019
Osteoarthritis: the genesis of pain K Fu, SR Robbins, JJ McDougall Rheumatology 57 (suppl_4), iv43-iv50	152	2018
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies I Pinal-Fernandez, M Casal-Dominguez, JA Huapaya, J Albayda, JJ Paik, ... Rheumatology 56 (6), 999-1007	146	2017
Clinical significance of Janus Kinase inhibitor selectivity EH Choy Rheumatology 58 (6), 953-962	144	2019
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis K Kurasawa, S Arai, Y Namiki, A Tanaka, Y Takamura, T Owada, M Arima, ... Rheumatology 57 (12), 2114-2119	140	2018
Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre MY Md Yusof, A Kabia, M Darby, G Lettieri, P Beirne, EM Vital, S Dass, ... Rheumatology 56 (8), 1348-1357	138	2017
Pathways leading to an immunological disease: systemic lupus erythematosus O Zharkova, T Celhar, PD Cravens, AB Satterthwaite, AM Fairhurst, ... Rheumatology 56 (suppl_1), i55-i66	138	2017
Digital ulcers in systemic sclerosis M Hughes, AL Herrick Rheumatology 56 (1), 14-25	138	2017
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial G Sircar, RP Goswami, D Sircar, A Ghosh, P Ghosh Rheumatology 57 (12), 2106-2113	137	2018
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis M Harigai Rheumatology 58 (Supplement_1), i34-i42	136	2019
Call for emergency action to limit global temperature increases, restore biodiversity and protect health L Atwoli, AH Baqui, T Benfield, R Bosurgi, F Godlee, S Hancocks, ... Rheumatology 60 (12), 5495-5497	134	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。